Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company

Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company

A wholly owned subsidiary of Eli Lilly and Company.

Location
Roles tracked
0
In pipeline
0
Tracking since

At a glance

You're tracking 0 roles at Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company. Track a role to start building momentum here.

Company intel

From the job board · LinkedIn data via posting sync
Industry
Biotechnology Research
Company size
160 people
Founded
2021
Type
Public Company
Total funding
$1.1B

Centessa Pharmaceuticals plc, a wholly owned subsidiary of Eli Lilly and Company, is developing a portfolio of orexin receptor 2 (OX2R) agonists for the potential treatment of sleep-wake and other neuroscience disorders.

Clinical Trials Life Science Biotechnology Pharmaceutical

Open roles at Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company